About Ikena Oncology, Inc. 
Ikena Oncology, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 18 Schemes (18.47%)
Foreign Institutions
Held by 21 Foreign Institutions (3.51%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-3 Million
Pharmaceuticals & Biotechnology
USD 152 Million ()
NA (Loss Making)
NA
0.00%
-0.79
-24.02%
1.31






